Release Date: April 11, 2017
Expiration date: October 11, 2017
Estimated Time to Complete Activity: 1.0 hour
CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
CME for MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
OVERVIEW
Comparisons of modern-day PCI versus cardiovascular surgery for the treatment of patients with left main disease have been the focus of several recent studies. This webcast lays out the options available to patients—and physicians—and gives a comprehensive review of the data from the EXCEL and NOBLE trials. Conversations highlight some of the unique methods and tools currently approved for use in Europe and what interventional cardiologists in the United States can anticipate for the future.
During this discussion, our expert panel tackles the evolving use of the SYNTAX score and individual patient risk factors to determine the appropriate approach to the treatment of left main lesions. Panelists will also review the patient population, design, choice of clinical endpoints, and key results from the recent pivotal trials in left main disease. Special attention is paid to considerations for patients with bifurcation left main coronary lesions and the relative merits of single versus dual artery stenting in this setting.
Watch and learn from this informative webcast, digest the latest data, and enjoy a glimpse of what the future holds.
LEARNING OBJECTIVES
After viewing this webcast, participants will be able to:
- Compare the available stents and treatments between Europe and the US
- Discuss the recent trials involving left main disease
- Explain how the treatment of left main disease will change in the future
TARGET AUDIENCE
This activity is designed for interventional cardiologists, cardiac surgeons, clinical cardiologists, vascular medicine specialists, and other health care professionals.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
FACULTY DISCLOSURE SUMMARY
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E) Equity (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
Matthew Price, MD
(C/H/S) Abbott Vascular, AstraZeneca, Boston Scientific Corporation, Medtronic, St. Jude Medical, The Medicines Company, W. L. Gore, Acist Medical
Alaide Chieffo, MD
None
Azeem Latib, MD, SM
(G/R) Medtronic, Direct flow Medical, Mitralign, 4Tech, Acist Medical (C/H/S) Medtronic, Direct Flow Medical, Mitralign, 4Tech, Acist Medical, Abbott Vascular, Valtech, Spectranetics, InnovaHeart, Millipede
Planning Committee
Arielle Gelardi (Planner)
(S) Cardiovascular Research Foundation
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation. It is supported through an educational grant from Medtronic Inc. and was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Arielle Gelardi at agelardi@crf.org